When is BIOX's latest earnings report released?
The most recent financial report for Bioceres crop solutions corp. (BIOX) covers the period of 2026Q2 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating BIOX's short-term business performance and financial health. For the latest updates on BIOX's earnings releases, visit this page regularly.
What is the operating profit of BIOX?
According to the latest financial report, Bioceres crop solutions corp. (BIOX) reported an Operating Profit of 7.45M with an Operating Margin of 10.06% this period, representing a decline of 1.43% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is BIOX's revenue growth?
In the latest financial report, Bioceres crop solutions corp. (BIOX) announced revenue of 74.04M, with a Year-Over-Year growth rate of -30.09%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does BIOX have?
As of the end of the reporting period, Bioceres crop solutions corp. (BIOX) had total debt of 239.46M, with a debt ratio of 0.43. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does BIOX have?
At the end of the period, Bioceres crop solutions corp. (BIOX) held Total Cash and Cash Equivalents of 11.06M, accounting for 0.02 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does BIOX go with three margins increasing?
In the latest report, Bioceres crop solutions corp. (BIOX) did not achieve the “three margins increasing” benchmark, with a gross margin of 36.3%%, operating margin of 10.06%%, and net margin of -6.8%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess BIOX's profit trajectory and future growth potential.
Is BIOX's EPS continuing to grow?
According to the past four quarterly reports, Bioceres crop solutions corp. (BIOX)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -2.8. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of BIOX?
Bioceres crop solutions corp. (BIOX)'s Free Cash Flow (FCF) for the period is 17.2M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 248.76% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of BIOX?
The latest valuation data shows Bioceres crop solutions corp. (BIOX) has a Price-To-Earnings (PE) ratio of -0.54 and a Price/Earnings-To-Growth (PEG) ratio of -0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.
